EUCTR2020-003661-19-AT进行中（未招募）1 期
Beta-blockade with landiolol in out-of-hospital cardiac arrest: a randomized, double-blind, placebo-controlled, pilot trial - Beta-blockade in cardiac arrest
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 入组人数
- 32
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •OHCA patient, more or equal than 18 years of age
- •Initial shockable rhythm (VF or pVT) as determined by the EMS team
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) no
- •F.1.2.1 Number of subjects for this age range 26
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range 6
排除标准
- •Initial rhythm pEA, asystole or unknown
- •Severe head trauma or acute active bleeding
- •Known allergy or insensitivity to landiolol or another beta-blocker
- •No treatment capacity at the emergency department of the Medical University of Vienna
研究者
相似试验
招募中
1 期
Beta-blockade With Landiolol in Out-of-hospital Cardiac ArrestCardiac ArrestNCT05554978Medical University of Vienna32
已完成
不适用
Effects of intravenous beta-blocker(landiolol) infusion after percutaneous coronary intervention for acute myocardial infarction patients.Acute myocardial infarctionJPRN-UMIN000003848Division of Cardiology, Saitama Medical Center, Saitama Medical University100
已完成
不适用
Safety and efficacy of intra-procedural landiolol, a very short acting beta-1 adrenergic receptor blocker, in primary percutaneous coronary intervention for acute myocardial infarctioAcute myocardial infarctionJPRN-UMIN000021668Yokohama City University Graduate School of Medicine Cardiorenal science55
进行中（未招募）
不适用
„Einsatz des Beta-Blockers Esmolol in Kombination mit dem Phosphodiesterase-III-Hemmer Enoximon im Vergleich zur alleinigen Gabe von Esmolol zur Optimierung der Hämodynamik bei Patienten mit koronarer Herzkrankheit - Esmolol-Perfan StudieEUCTR2005-004617-15-DEKlinik für Anästhesiologie und Operative Intensivmedizin Klinikum Ludwigshafen
招募中
不适用
The study of the usefulness of beta-blocker for hypertensive patients with persistent atrial fibrillation combined with reduced cardiac functiohypertensive patients with persistent atrial fibrillation combined with reduced cardiac functionJPRN-UMIN000001848ihon University School of Medicine20